pubmed-article:7691631 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7691631 | lifeskim:mentions | umls-concept:C0025914 | lld:lifeskim |
pubmed-article:7691631 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:7691631 | lifeskim:mentions | umls-concept:C0029000 | lld:lifeskim |
pubmed-article:7691631 | lifeskim:mentions | umls-concept:C0155090 | lld:lifeskim |
pubmed-article:7691631 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:7691631 | pubmed:dateCreated | 1993-10-27 | lld:pubmed |
pubmed-article:7691631 | pubmed:abstractText | Sclerosing keratitis is the major cause of blindness due to onchocerciasis; its pathogenesis is poorly understood. We have previously reported an immune-mediated model of experimental interstitial keratitis in guinea pigs following intrastromal challenge with soluble antigens from Onchocerca volvulus. This model system is ideal for evaluation of pathogenicity of multiple purified antigen preparations; however, reagents necessary for detailed immunologic analysis of the inflammatory cellular infiltrate are not yet available for guinea pigs. Because of the ready availability of these reagents for mice, a mouse model has been developed. The inflammatory response observed in this model was analogous to that seen in human onchocercal sclerosing keratitis as well as in the guinea pig model of onchocercal sclerosing keratitis. Granulocytes were present in the acute inflammatory response, whereas the chronic response showed lymphocytes, plasma cells, and histiocytes. Neovascularization and scarring of the corneal stroma was also observed. This model will be helpful in examining the mechanisms of immunopathogenesis and the contribution of the host genetic background to the disease. | lld:pubmed |
pubmed-article:7691631 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7691631 | pubmed:language | eng | lld:pubmed |
pubmed-article:7691631 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7691631 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7691631 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7691631 | pubmed:month | Jul | lld:pubmed |
pubmed-article:7691631 | pubmed:issn | 0014-4835 | lld:pubmed |
pubmed-article:7691631 | pubmed:author | pubmed-author:DiaconuEE | lld:pubmed |
pubmed-article:7691631 | pubmed:author | pubmed-author:LassJ HJH | lld:pubmed |
pubmed-article:7691631 | pubmed:author | pubmed-author:GreeneB MBM | lld:pubmed |
pubmed-article:7691631 | pubmed:author | pubmed-author:BardensteinD... | lld:pubmed |
pubmed-article:7691631 | pubmed:author | pubmed-author:ChakravartiD... | lld:pubmed |
pubmed-article:7691631 | pubmed:author | pubmed-author:ChakravartiBB | lld:pubmed |
pubmed-article:7691631 | pubmed:author | pubmed-author:RoyC ECE | lld:pubmed |
pubmed-article:7691631 | pubmed:author | pubmed-author:HerringT ATA | lld:pubmed |
pubmed-article:7691631 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7691631 | pubmed:volume | 57 | lld:pubmed |
pubmed-article:7691631 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7691631 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7691631 | pubmed:pagination | 21-7 | lld:pubmed |
pubmed-article:7691631 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:meshHeading | pubmed-meshheading:7691631-... | lld:pubmed |
pubmed-article:7691631 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:7691631 | pubmed:articleTitle | Immune-mediated Onchocerca volvulus sclerosing keratitis in the mouse. | lld:pubmed |
pubmed-article:7691631 | pubmed:affiliation | Department of Medicine, University of Alabama at Birmingham 35205. | lld:pubmed |
pubmed-article:7691631 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7691631 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:7691631 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7691631 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7691631 | lld:pubmed |